Pharmacokinetics of Cefoselis during Continuous Renal Replacement Therapy in Critically Ill Patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-14004869

Enrollment

Unknown

Registered

2014-06-26

Start date

2014-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Failure

Interventions

Renal Failure Group:cefoselis

CRRT Group:cefoselis

Eligibility

Sex/Gender

Male

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) older than 18 years old; 2) severe renal failure (acute or chronic); 3) cefoselis were prescribed as a part of their required medical care.

Exclusion criteria

Exclusion criteria: 1) complicated with hepatic failure; 2) Cefoselis skin test is positive; 3) cephalosporins was used in a week; 4) performing peritoneal dialysis.

Design outcomes

Primary

Measure	Time frame
plasma drug concentration;	—

Countries

China

Contacts

Public ContactYuanfeng Shi

The First Renmin Hospital of Lianyungang

winets@126.com+86 18961326700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026